This randomised controlled trial from Australia reported on the efficacy of gabapentin in chronic refractory cough and investigated its role in modulating central sensitisation (CS) of the cough reflex.

Recruitment of 62 patients was conducted over 2 years. Fifty-two patients completed the trial. All were non-smokers with a cough of more than 8 weeks’ duration and had negative investigation …